The synthesis and biological activity of a series of novel 5-substituted-4-hydroxy-8- nitroquinazolines that may function as inhibitors of EGFR-and/or ErbB-2-related oncogenic signaling are described. These compounds were prepared by SNAr reaction of 5-chloro-4- hydroxy-8-nitroquinazoline with alkyl or aryl amines, or alkyl alcohol as nucleophiles. Although the enzyme assay showed a weak inhibition effect against both EGFR and ErbB- ...